Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Tirode

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
The American Journal of Surgical Pathology|August 1, 2020
Cutaneous Melanocytic Tumors With Concomitant NRASQ61R and IDH1R132C Mutations: A Report of 6 CasesNicolas Macagno, Daniel Pissaloux, Heather Etchevers, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2023
GRM1 Gene Fusions as an Alternative Molecular Driver in Blue Nevi and Related MelanomasThibault Kervarrec, Giuseppe Lo Bello, Daniel Pissaloux, et al.
Pigment Cell & Melanoma Research|July 26, 2021
RASGRF2 gene fusions identified in a variety of melanocytic lesions with distinct morphological featuresAurélie Houlier, Daniel Pissaloux, Franck Tirode, et al.
Virchows Archiv : an International Journal of Pathology|January 21, 2026
Primary cutaneous non neuroendocrine small cell carcinoma POU2F3 subtype: morphologic, immunohistochemical, transcriptomic and methylation analysis of two casesKerman Zyani, Daniel Pissaloux, Charly Liddell, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2024
MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic DifferentiationJennifer S Ko, Julie Lemahieu, Steven D Billings, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 20, 2023
Histologic and Genetic Features of 51 Melanocytic Neoplasms With Protein Kinase C Fusion GenesArnaud de la Fouchardière, Daniel Pissaloux, Aurélie Houlier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survivalGaëlle Picarda, François Lamoureux, Loïc Geffroy, et al.
Nature Genetics|March 6, 2012
A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusionGaëlle Pierron, Franck Tirode, Carlo Lucchesi, et al.
The American Journal of Surgical Pathology|December 20, 2023
Melanotic PEComa: A Rare But Distinctive Subtype Analyzed in a Series of 7 CasesArnaud de la Fouchardiere, David J Papke, Daniel Pissaloux, et al.
Molecular Cancer Research : MCR|January 20, 2012
A functional, new short isoform of death receptor 4 in Ewing's sarcoma cell lines may be involved in TRAIL sensitivity/resistance mechanismsGaëlle Picarda, Sylvanie Surget, Romain Guiho, et al.
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
The American Journal of Surgical Pathology|August 1, 2020
Cutaneous Melanocytic Tumors With Concomitant NRASQ61R and IDH1R132C Mutations: A Report of 6 CasesNicolas Macagno, Daniel Pissaloux, Heather Etchevers, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2023
GRM1 Gene Fusions as an Alternative Molecular Driver in Blue Nevi and Related MelanomasThibault Kervarrec, Giuseppe Lo Bello, Daniel Pissaloux, et al.
Pigment Cell & Melanoma Research|July 26, 2021
RASGRF2 gene fusions identified in a variety of melanocytic lesions with distinct morphological featuresAurélie Houlier, Daniel Pissaloux, Franck Tirode, et al.
Virchows Archiv : an International Journal of Pathology|January 21, 2026
Primary cutaneous non neuroendocrine small cell carcinoma POU2F3 subtype: morphologic, immunohistochemical, transcriptomic and methylation analysis of two casesKerman Zyani, Daniel Pissaloux, Charly Liddell, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2024
MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic DifferentiationJennifer S Ko, Julie Lemahieu, Steven D Billings, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 20, 2023
Histologic and Genetic Features of 51 Melanocytic Neoplasms With Protein Kinase C Fusion GenesArnaud de la Fouchardière, Daniel Pissaloux, Aurélie Houlier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survivalGaëlle Picarda, François Lamoureux, Loïc Geffroy, et al.
Nature Genetics|March 6, 2012
A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusionGaëlle Pierron, Franck Tirode, Carlo Lucchesi, et al.
The American Journal of Surgical Pathology|December 20, 2023
Melanotic PEComa: A Rare But Distinctive Subtype Analyzed in a Series of 7 CasesArnaud de la Fouchardiere, David J Papke, Daniel Pissaloux, et al.
Molecular Cancer Research : MCR|January 20, 2012
A functional, new short isoform of death receptor 4 in Ewing's sarcoma cell lines may be involved in TRAIL sensitivity/resistance mechanismsGaëlle Picarda, Sylvanie Surget, Romain Guiho, et al.
Pageof 14